192 related articles for article (PubMed ID: 10897003)
41. Monoclonal antibody 806 inhibits the growth of tumor xenografts expressing either the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR.
Luwor RB; Johns TG; Murone C; Huang HJ; Cavenee WK; Ritter G; Old LJ; Burgess AW; Scott AM
Cancer Res; 2001 Jul; 61(14):5355-61. PubMed ID: 11454674
[TBL] [Abstract][Full Text] [Related]
42. Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase A.
Ciardiello F; Damiano V; Bianco R; Bianco C; Fontanini G; De Laurentiis M; De Placido S; Mendelsohn J; Bianco AR; Tortora G
J Natl Cancer Inst; 1996 Dec; 88(23):1770-6. PubMed ID: 8944008
[TBL] [Abstract][Full Text] [Related]
43. Therapeutic potential of amanitin-conjugated anti-epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinoma.
Moldenhauer G; Salnikov AV; Lüttgau S; Herr I; Anderl J; Faulstich H
J Natl Cancer Inst; 2012 Apr; 104(8):622-34. PubMed ID: 22457476
[TBL] [Abstract][Full Text] [Related]
44. A recombinant humanized anti-insulin-like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti-epidermal growth factor receptor therapy against human cancer xenografts.
Goetsch L; Gonzalez A; Leger O; Beck A; Pauwels PJ; Haeuw JF; Corvaia N
Int J Cancer; 2005 Jan; 113(2):316-28. PubMed ID: 15386423
[TBL] [Abstract][Full Text] [Related]
45. Site-specific conjugation of boron-containing dendrimers to anti-EGF receptor monoclonal antibody cetuximab (IMC-C225) and its evaluation as a potential delivery agent for neutron capture therapy.
Wu G; Barth RF; Yang W; Chatterjee M; Tjarks W; Ciesielski MJ; Fenstermaker RA
Bioconjug Chem; 2004; 15(1):185-94. PubMed ID: 14733599
[TBL] [Abstract][Full Text] [Related]
46. IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody, for treatment of head and neck cancer.
Herbst RS; Kim ES; Harari PM
Expert Opin Biol Ther; 2001 Jul; 1(4):719-32. PubMed ID: 11727507
[TBL] [Abstract][Full Text] [Related]
47. Activity of anti-epidermal growth factor receptor monoclonal antibody C225 against glioblastoma multiforme.
Eller JL; Longo SL; Hicklin DJ; Canute GW
Neurosurgery; 2002 Oct; 51(4):1005-13; discussion 1013-4. PubMed ID: 12234411
[TBL] [Abstract][Full Text] [Related]
48. Conservation of receptor antagonist anti-tumor activity by epidermal growth factor receptor antibody expressed in transgenic corn seed.
Ludwig DL; Witte L; Hicklin DJ; Prewett M; Bassi R; Burtrum D; Pereira DS; Jimenez X; Fox F; Saxena B; Zhou Q; Ma Y; Kang X; Patel D; Barry M; Kussie P; Zhu Z; Russell DA; Petersen WL; Jury TP; Gaitan-Gaitan F; Moran DL; Delannay X; Storrs BS; Tou J; Zupec ME; Gustafson KS; McIntyre J; Tarnowski SJ; Bohlen P
Hum Antibodies; 2004; 13(3):81-90. PubMed ID: 15598988
[TBL] [Abstract][Full Text] [Related]
49. Differential responses by pancreatic carcinoma cell lines to prolonged exposure to Erbitux (IMC-C225) anti-EGFR antibody.
Huang ZQ; Buchsbaum DJ; Raisch KP; Bonner JA; Bland KI; Vickers SM
J Surg Res; 2003 May; 111(2):274-83. PubMed ID: 12850474
[TBL] [Abstract][Full Text] [Related]
50. Restoring apoptosis in pancreatic cancer cells by targeting the nuclear factor-kappaB signaling pathway with the anti-epidermal growth factor antibody IMC-C225.
Sclabas GM; Fujioka S; Schmidt C; Fan Z; Evans DB; Chiao PJ
J Gastrointest Surg; 2003 Jan; 7(1):37-43; discussion 43. PubMed ID: 12559183
[TBL] [Abstract][Full Text] [Related]
51. Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies.
Baselga J; Norton L; Masui H; Pandiella A; Coplan K; Miller WH; Mendelsohn J
J Natl Cancer Inst; 1993 Aug; 85(16):1327-33. PubMed ID: 8340945
[TBL] [Abstract][Full Text] [Related]
52. In vivo therapeutic synergism of anti-epidermal growth factor receptor and anti-HER2 monoclonal antibodies against pancreatic carcinomas.
Larbouret C; Robert B; Navarro-Teulon I; Thèzenas S; Ladjemi MZ; Morisseau S; Campigna E; Bibeau F; Mach JP; Pèlegrin A; Azria D
Clin Cancer Res; 2007 Jun; 13(11):3356-62. PubMed ID: 17545543
[TBL] [Abstract][Full Text] [Related]
53. Radiosensitivity of prostate cancer cells is enhanced by EGFR inhibitor C225.
Liu F; Wang JJ; You ZY; Zhang YD; Zhao Y
Urol Oncol; 2010; 28(1):59-66. PubMed ID: 18799330
[TBL] [Abstract][Full Text] [Related]
54. The epidermal growth factor receptor as a target for cancer therapy.
Mendelsohn J
Endocr Relat Cancer; 2001 Mar; 8(1):3-9. PubMed ID: 11350723
[TBL] [Abstract][Full Text] [Related]
55. Cooperative inhibition of renal cancer growth by anti-epidermal growth factor receptor antibody and protein kinase A antisense oligonucleotide.
Ciardiello F; Caputo R; Bianco R; Damiano V; Pomatico G; Pepe S; Bianco AR; Agrawal S; Mendelsohn J; Tortora G
J Natl Cancer Inst; 1998 Jul; 90(14):1087-94. PubMed ID: 9672257
[TBL] [Abstract][Full Text] [Related]
56. Magnetic resonance imaging in an orthotopic rat model: blockade of epidermal growth factor receptor with EMD72000 inhibits human pancreatic carcinoma growth.
Bangard C; Gossmann A; Papyan A; Tawadros S; Hellmich M; Bruns CJ
Int J Cancer; 2005 Mar; 114(1):131-8. PubMed ID: 15523683
[TBL] [Abstract][Full Text] [Related]
57. Epidermal growth factor receptor biology (IMC-C225).
Kim ES; Khuri FR; Herbst RS
Curr Opin Oncol; 2001 Nov; 13(6):506-13. PubMed ID: 11673692
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of human tumor xenograft growth in nude mice by a conjugate of monoclonal antibody LA22 to epidermal growth factor receptor with anti-tumor antibiotics mitomycin C.
Shao W; Zhao S; Liu Z; Zhang J; Ma S; Sato JD; Zhang P; Tong M; Han J; Wang Y; Bai D; Wang F; Sun L
Biochem Biophys Res Commun; 2006 Oct; 349(2):816-24. PubMed ID: 16950201
[TBL] [Abstract][Full Text] [Related]
59. Cetuximab in combination with anti-human IgG antibodies efficiently down-regulates the EGF receptor by macropinocytosis.
Berger C; Madshus IH; Stang E
Exp Cell Res; 2012 Dec; 318(20):2578-91. PubMed ID: 22975728
[TBL] [Abstract][Full Text] [Related]
60. Anti-EGFR-mediated radiosensitization as a result of augmented EGFR expression.
Bonner JA; Buchsbaum DJ; Russo SM; Fiveash JB; Trummell HQ; Curiel DT; Raisch KP
Int J Radiat Oncol Biol Phys; 2004; 59(2 Suppl):2-10. PubMed ID: 15142629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
